Method of antagonizing the effects of thromboxane
US4536510A · kind A · utility
7Cited by
2References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 1983 |
| Grant date | Aug 20, 1985 |
| Priority date | — |
| Expiry date | Jul 22, 2003 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/47
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of antagonizing the effects of thromboxane A.sub.2 in the circulatory system of an animal which comprises administering to said animal a nontoxic effective amount of N,N'-bis[7-(3-chlorobenzeneaminosulfonyl)-1,2,3,4-tetrahydroisoquinolyl]di sulfonylimide or a pharamaceutical acceptable salt thereof are valuable in the treatment of diseases in which thromboxane A.sub.2 is a factor, such as thrombosis, endotoxic shock and cardiac anaphylaxis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.